Innovation pipelines
Our institute has a wide range of technologies, capabilities and services available to industry.
Vaccines
Antigen discovery | Vaccine prototype | Preclinical studies | Phase 1 trials | Available/ Partnered | |
|---|---|---|---|---|---|
Group A Streptococcus (peptide conjugate) | x | x | x | x | A |
Group A Streptococcus (liposomal formulation) | x | x | x | P | |
Malaria (attenuated whole parasite blood stage) | x | x | x | x | A |
Neisseria gonorrhoeae (antigen) | x | x | A | ||
Chikungunya virus (attenuated virus) | x | x | n | A | |
Zika virus (attenuated virus) | x | x | A | ||
MultiVax (multiple antigen platform) | x | x | n | A |
Drugs
Target Discovery | Hits / | Preclinical studies | Phase 1 trials | Available/ Partnered | |
|---|---|---|---|---|---|
Ross River Virus (small molecule) | x | x | x | x | P |
Human Parainfluenza Virus 1 & 3 (small molecule) | x | x | A | ||
Influenza (small molecule) | x | x | A | ||
Enterovirus 71 (small molecule) | x | x | A | ||
Sepsis (small molecule) | x | x | x | x | P |
Anticancer agent (peptide inhibitor) | x | x | A |
Diagnostics, technology platforms and other
POC | Prototype | Lead Product | Available/ Partnered | |
|---|---|---|---|---|
Cancer diagnostic (biomarker) | x | A | ||
Glycan Array (platform product) | x | x | x | P |
Prebiotics and nutritional products | x | A |